Nigel C. Jones

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

Medicine, Endocrinology, Pharmacotherapy +13

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · The Lancet · 2009 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · New England Journal of Medicine · 2007 · 763 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

A Diabetes Outcome Progression Trial (ADOPT)

Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene et al. · Diabetes Care · 2002 · 272 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17